10-K
Annual Report
Translational Development Acquisition Corp. TDAC TDACU TDACW
0001410578-25-000576
- Filed
- Mar 31, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Dec 31, 2024 | 0 sh |
| Shares Outstanding | FY 2024 · Dec 31, 2023 | 0 sh |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$204 |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $2.02K |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $509.68K |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $509.68K |
| Current Assets | FY 2024 · Dec 31, 2023 | $2.02K |
| Total Assets | FY 2024 · Dec 31, 2023 | $2.02K |
| Net Income | FY 2024 · Dec 31, 2023 | −$485.55K |
| Operating Income | FY 2024 · Dec 31, 2023 | −$485.55K |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | −$22.11K |